nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.132	0.222	CbGbCtD
Eszopiclone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0919	0.155	CbGbCtD
Eszopiclone—CYP2C8—Progesterone—uterine cancer	0.0873	0.147	CbGbCtD
Eszopiclone—PTGS1—Etoposide—uterine cancer	0.0677	0.114	CbGbCtD
Eszopiclone—CYP2C9—Progesterone—uterine cancer	0.0609	0.102	CbGbCtD
Eszopiclone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0534	0.09	CbGbCtD
Eszopiclone—CYP2C8—Etoposide—uterine cancer	0.039	0.0658	CbGbCtD
Eszopiclone—CYP3A4—Progesterone—uterine cancer	0.0354	0.0596	CbGbCtD
Eszopiclone—CYP3A4—Etoposide—uterine cancer	0.0158	0.0267	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—uterine cancer	0.0108	0.0182	CbGbCtD
Eszopiclone—TSPO—oviduct—uterine cancer	0.00611	0.115	CbGeAlD
Eszopiclone—TSPO—artery—uterine cancer	0.00405	0.076	CbGeAlD
Eszopiclone—TSPO—exocrine gland—uterine cancer	0.00353	0.0662	CbGeAlD
Eszopiclone—PTGS1—oviduct—uterine cancer	0.0034	0.0639	CbGeAlD
Eszopiclone—PTGS1—artery—uterine cancer	0.00225	0.0423	CbGeAlD
Eszopiclone—TSPO—myometrium—uterine cancer	0.00196	0.0367	CbGeAlD
Eszopiclone—GABRA4—mammalian vulva—uterine cancer	0.00188	0.0353	CbGeAlD
Eszopiclone—TSPO—epithelium—uterine cancer	0.00153	0.0288	CbGeAlD
Eszopiclone—TSPO—uterine cervix—uterine cancer	0.00152	0.0286	CbGeAlD
Eszopiclone—TSPO—smooth muscle tissue—uterine cancer	0.00148	0.0278	CbGeAlD
Eszopiclone—TSPO—decidua—uterine cancer	0.00145	0.0272	CbGeAlD
Eszopiclone—TSPO—renal system—uterine cancer	0.00142	0.0267	CbGeAlD
Eszopiclone—TSPO—endometrium—uterine cancer	0.00138	0.0258	CbGeAlD
Eszopiclone—TSPO—mammalian vulva—uterine cancer	0.00133	0.025	CbGeAlD
Eszopiclone—TSPO—uterus—uterine cancer	0.00127	0.0238	CbGeAlD
Eszopiclone—TSPO—female reproductive system—uterine cancer	0.00114	0.0214	CbGeAlD
Eszopiclone—GABRA2—vagina—uterine cancer	0.00111	0.0209	CbGeAlD
Eszopiclone—TSPO—female gonad—uterine cancer	0.00104	0.0195	CbGeAlD
Eszopiclone—TSPO—vagina—uterine cancer	0.00103	0.0194	CbGeAlD
Eszopiclone—CYP2C8—renal system—uterine cancer	0.000977	0.0183	CbGeAlD
Eszopiclone—CYP2C8—endometrium—uterine cancer	0.000944	0.0177	CbGeAlD
Eszopiclone—PTGS1—epithelium—uterine cancer	0.000854	0.016	CbGeAlD
Eszopiclone—PTGS1—uterine cervix—uterine cancer	0.000847	0.0159	CbGeAlD
Eszopiclone—PTGS1—smooth muscle tissue—uterine cancer	0.000823	0.0155	CbGeAlD
Eszopiclone—PTGS1—renal system—uterine cancer	0.000792	0.0149	CbGeAlD
Eszopiclone—CYP2C8—female reproductive system—uterine cancer	0.000782	0.0147	CbGeAlD
Eszopiclone—PTGS1—endometrium—uterine cancer	0.000766	0.0144	CbGeAlD
Eszopiclone—PTGS1—mammalian vulva—uterine cancer	0.000741	0.0139	CbGeAlD
Eszopiclone—GABRA2—lymph node—uterine cancer	0.00072	0.0135	CbGeAlD
Eszopiclone—CYP2C8—vagina—uterine cancer	0.000708	0.0133	CbGeAlD
Eszopiclone—PTGS1—uterus—uterine cancer	0.000706	0.0132	CbGeAlD
Eszopiclone—CYP2C9—female reproductive system—uterine cancer	0.000695	0.013	CbGeAlD
Eszopiclone—TSPO—lymph node—uterine cancer	0.000667	0.0125	CbGeAlD
Eszopiclone—CYP3A4—renal system—uterine cancer	0.000662	0.0124	CbGeAlD
Eszopiclone—PTGS1—female reproductive system—uterine cancer	0.000634	0.0119	CbGeAlD
Eszopiclone—PTGS1—female gonad—uterine cancer	0.000577	0.0108	CbGeAlD
Eszopiclone—PTGS1—vagina—uterine cancer	0.000574	0.0108	CbGeAlD
Eszopiclone—CYP3A4—female reproductive system—uterine cancer	0.00053	0.00995	CbGeAlD
Eszopiclone—PTGS1—lymph node—uterine cancer	0.000371	0.00697	CbGeAlD
Eszopiclone—Dermatitis—Progesterone—uterine cancer	0.000316	0.000896	CcSEcCtD
Eszopiclone—Headache—Progesterone—uterine cancer	0.000314	0.000891	CcSEcCtD
Eszopiclone—Thrombophlebitis—Doxorubicin—uterine cancer	0.000313	0.000887	CcSEcCtD
Eszopiclone—Increased appetite—Epirubicin—uterine cancer	0.000312	0.000883	CcSEcCtD
Eszopiclone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.000882	CcSEcCtD
Eszopiclone—Photosensitivity—Doxorubicin—uterine cancer	0.000308	0.000874	CcSEcCtD
Eszopiclone—Decreased appetite—Dactinomycin—uterine cancer	0.000308	0.000874	CcSEcCtD
Eszopiclone—Dysgeusia—Etoposide—uterine cancer	0.000308	0.000873	CcSEcCtD
Eszopiclone—Dermatitis bullous—Epirubicin—uterine cancer	0.000306	0.000868	CcSEcCtD
Eszopiclone—Fatigue—Dactinomycin—uterine cancer	0.000306	0.000866	CcSEcCtD
Eszopiclone—Back pain—Etoposide—uterine cancer	0.000304	0.000862	CcSEcCtD
Eszopiclone—Pain—Dactinomycin—uterine cancer	0.000303	0.000859	CcSEcCtD
Eszopiclone—Muscle spasms—Etoposide—uterine cancer	0.000302	0.000857	CcSEcCtD
Eszopiclone—Eczema—Doxorubicin—uterine cancer	0.000301	0.000854	CcSEcCtD
Eszopiclone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.000852	CcSEcCtD
Eszopiclone—Nausea—Progesterone—uterine cancer	0.000298	0.000845	CcSEcCtD
Eszopiclone—Osteoarthritis—Epirubicin—uterine cancer	0.000293	0.00083	CcSEcCtD
Eszopiclone—Diplopia—Epirubicin—uterine cancer	0.000293	0.00083	CcSEcCtD
Eszopiclone—Feeling abnormal—Dactinomycin—uterine cancer	0.000292	0.000828	CcSEcCtD
Eszopiclone—Ill-defined disorder—Etoposide—uterine cancer	0.000292	0.000827	CcSEcCtD
Eszopiclone—Anaemia—Etoposide—uterine cancer	0.000291	0.000824	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00029	0.000822	CcSEcCtD
Eszopiclone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000289	0.000819	CcSEcCtD
Eszopiclone—Increased appetite—Doxorubicin—uterine cancer	0.000288	0.000817	CcSEcCtD
Eszopiclone—Affect lability—Epirubicin—uterine cancer	0.000288	0.000817	CcSEcCtD
Eszopiclone—Migraine—Epirubicin—uterine cancer	0.000288	0.000817	CcSEcCtD
Eszopiclone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.000812	CcSEcCtD
Eszopiclone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.000812	CcSEcCtD
Eszopiclone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.000807	CcSEcCtD
Eszopiclone—Malaise—Etoposide—uterine cancer	0.000284	0.000804	CcSEcCtD
Eszopiclone—Dermatitis bullous—Doxorubicin—uterine cancer	0.000283	0.000803	CcSEcCtD
Eszopiclone—Face oedema—Epirubicin—uterine cancer	0.000283	0.000801	CcSEcCtD
Eszopiclone—Vertigo—Etoposide—uterine cancer	0.000283	0.000801	CcSEcCtD
Eszopiclone—Abdominal pain—Dactinomycin—uterine cancer	0.00028	0.000794	CcSEcCtD
Eszopiclone—Body temperature increased—Dactinomycin—uterine cancer	0.00028	0.000794	CcSEcCtD
Eszopiclone—Mood swings—Epirubicin—uterine cancer	0.000277	0.000786	CcSEcCtD
Eszopiclone—Ataxia—Epirubicin—uterine cancer	0.000275	0.00078	CcSEcCtD
Eszopiclone—Convulsion—Etoposide—uterine cancer	0.000272	0.000772	CcSEcCtD
Eszopiclone—Dehydration—Epirubicin—uterine cancer	0.000272	0.000771	CcSEcCtD
Eszopiclone—Hypertension—Etoposide—uterine cancer	0.000272	0.000769	CcSEcCtD
Eszopiclone—Diplopia—Doxorubicin—uterine cancer	0.000271	0.000768	CcSEcCtD
Eszopiclone—Osteoarthritis—Doxorubicin—uterine cancer	0.000271	0.000768	CcSEcCtD
Eszopiclone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00027	0.000765	CcSEcCtD
Eszopiclone—Dry skin—Epirubicin—uterine cancer	0.000268	0.00076	CcSEcCtD
Eszopiclone—Chest pain—Etoposide—uterine cancer	0.000268	0.000759	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—uterine cancer	0.000267	0.000756	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—uterine cancer	0.000267	0.000756	CcSEcCtD
Eszopiclone—Hypokalaemia—Epirubicin—uterine cancer	0.000266	0.000755	CcSEcCtD
Eszopiclone—Discomfort—Etoposide—uterine cancer	0.000265	0.00075	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000264	0.000747	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—uterine cancer	0.000261	0.000741	CcSEcCtD
Eszopiclone—Hypersensitivity—Dactinomycin—uterine cancer	0.000261	0.00074	CcSEcCtD
Eszopiclone—Gastritis—Epirubicin—uterine cancer	0.000259	0.000734	CcSEcCtD
Eszopiclone—Confusional state—Etoposide—uterine cancer	0.000259	0.000733	CcSEcCtD
Eszopiclone—Muscular weakness—Epirubicin—uterine cancer	0.000258	0.000732	CcSEcCtD
Eszopiclone—Anaphylactic shock—Etoposide—uterine cancer	0.000257	0.000727	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—uterine cancer	0.000257	0.000727	CcSEcCtD
Eszopiclone—Infection—Etoposide—uterine cancer	0.000255	0.000723	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—uterine cancer	0.000255	0.000722	CcSEcCtD
Eszopiclone—Asthenia—Dactinomycin—uterine cancer	0.000254	0.000721	CcSEcCtD
Eszopiclone—Dysphagia—Epirubicin—uterine cancer	0.000253	0.000717	CcSEcCtD
Eszopiclone—Asthma—Epirubicin—uterine cancer	0.000253	0.000717	CcSEcCtD
Eszopiclone—Influenza—Epirubicin—uterine cancer	0.000253	0.000717	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—uterine cancer	0.000252	0.000714	CcSEcCtD
Eszopiclone—Tachycardia—Etoposide—uterine cancer	0.000251	0.00071	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—uterine cancer	0.000248	0.000704	CcSEcCtD
Eszopiclone—Hyperhidrosis—Etoposide—uterine cancer	0.000248	0.000703	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—uterine cancer	0.000247	0.000699	CcSEcCtD
Eszopiclone—Anorexia—Etoposide—uterine cancer	0.000245	0.000693	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000244	0.000691	CcSEcCtD
Eszopiclone—Bronchitis—Epirubicin—uterine cancer	0.000243	0.00069	CcSEcCtD
Eszopiclone—Diarrhoea—Dactinomycin—uterine cancer	0.000243	0.000688	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—uterine cancer	0.00024	0.000679	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—uterine cancer	0.000239	0.000677	CcSEcCtD
Eszopiclone—Dysuria—Epirubicin—uterine cancer	0.000237	0.00067	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—uterine cancer	0.000234	0.000663	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—uterine cancer	0.000234	0.000663	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—uterine cancer	0.000234	0.000663	CcSEcCtD
Eszopiclone—Pollakiuria—Epirubicin—uterine cancer	0.000234	0.000662	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—uterine cancer	0.000231	0.000654	CcSEcCtD
Eszopiclone—Paraesthesia—Etoposide—uterine cancer	0.00023	0.000653	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—uterine cancer	0.00023	0.000652	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—uterine cancer	0.000229	0.000649	CcSEcCtD
Eszopiclone—Dyspnoea—Etoposide—uterine cancer	0.000229	0.000648	CcSEcCtD
Eszopiclone—Somnolence—Etoposide—uterine cancer	0.000228	0.000647	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—uterine cancer	0.000226	0.000639	CcSEcCtD
Eszopiclone—Vomiting—Dactinomycin—uterine cancer	0.000225	0.000639	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—uterine cancer	0.000225	0.000638	CcSEcCtD
Eszopiclone—Rash—Dactinomycin—uterine cancer	0.000224	0.000634	CcSEcCtD
Eszopiclone—Decreased appetite—Etoposide—uterine cancer	0.000223	0.000632	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000222	0.000628	CcSEcCtD
Eszopiclone—Fatigue—Etoposide—uterine cancer	0.000221	0.000627	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—uterine cancer	0.000221	0.000627	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—uterine cancer	0.00022	0.000623	CcSEcCtD
Eszopiclone—Pain—Etoposide—uterine cancer	0.000219	0.000622	CcSEcCtD
Eszopiclone—Constipation—Etoposide—uterine cancer	0.000219	0.000622	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—uterine cancer	0.000219	0.000621	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—uterine cancer	0.000219	0.000621	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—uterine cancer	0.000219	0.00062	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—uterine cancer	0.000216	0.000613	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—uterine cancer	0.000216	0.000613	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—uterine cancer	0.000215	0.00061	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000214	0.000606	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—uterine cancer	0.000213	0.000604	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—uterine cancer	0.000213	0.000603	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—uterine cancer	0.000212	0.0006	CcSEcCtD
Eszopiclone—Feeling abnormal—Etoposide—uterine cancer	0.000212	0.000599	CcSEcCtD
Eszopiclone—Nausea—Dactinomycin—uterine cancer	0.000211	0.000597	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Etoposide—uterine cancer	0.00021	0.000595	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—uterine cancer	0.000209	0.000592	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000205	0.00058	CcSEcCtD
Eszopiclone—Urticaria—Etoposide—uterine cancer	0.000204	0.000578	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—uterine cancer	0.000203	0.000577	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—uterine cancer	0.000203	0.000575	CcSEcCtD
Eszopiclone—Body temperature increased—Etoposide—uterine cancer	0.000203	0.000575	CcSEcCtD
Eszopiclone—Abdominal pain—Etoposide—uterine cancer	0.000203	0.000575	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—uterine cancer	0.000203	0.000575	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—uterine cancer	0.000203	0.000575	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—uterine cancer	0.000203	0.000574	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—uterine cancer	0.000201	0.000571	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—uterine cancer	0.000201	0.00057	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—uterine cancer	0.0002	0.000567	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—uterine cancer	0.000199	0.000565	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—uterine cancer	0.000199	0.000564	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—uterine cancer	0.000197	0.000558	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—uterine cancer	0.000191	0.000543	CcSEcCtD
Eszopiclone—Hypersensitivity—Etoposide—uterine cancer	0.000189	0.000536	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—uterine cancer	0.000189	0.000535	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—uterine cancer	0.000188	0.000532	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—uterine cancer	0.000187	0.000531	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—uterine cancer	0.000186	0.000528	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—uterine cancer	0.000186	0.000527	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—uterine cancer	0.000185	0.000523	CcSEcCtD
Eszopiclone—Asthenia—Etoposide—uterine cancer	0.000184	0.000522	CcSEcCtD
Eszopiclone—Chills—Epirubicin—uterine cancer	0.000182	0.000515	CcSEcCtD
Eszopiclone—Pruritus—Etoposide—uterine cancer	0.000182	0.000515	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—uterine cancer	0.000179	0.000507	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—uterine cancer	0.000177	0.000502	CcSEcCtD
Eszopiclone—Diarrhoea—Etoposide—uterine cancer	0.000176	0.000498	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—uterine cancer	0.000175	0.000495	CcSEcCtD
Eszopiclone—Tension—Epirubicin—uterine cancer	0.000173	0.00049	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—uterine cancer	0.000173	0.000489	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—uterine cancer	0.000171	0.000485	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—uterine cancer	0.000171	0.000483	CcSEcCtD
Eszopiclone—Dizziness—Etoposide—uterine cancer	0.00017	0.000481	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—uterine cancer	0.000169	0.00048	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—uterine cancer	0.000168	0.000476	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—uterine cancer	0.000166	0.000471	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—uterine cancer	0.000166	0.000469	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—uterine cancer	0.000164	0.000464	CcSEcCtD
Eszopiclone—Vomiting—Etoposide—uterine cancer	0.000163	0.000462	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—uterine cancer	0.000163	0.000462	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—uterine cancer	0.000162	0.000459	CcSEcCtD
Eszopiclone—Rash—Etoposide—uterine cancer	0.000162	0.000459	CcSEcCtD
Eszopiclone—Dermatitis—Etoposide—uterine cancer	0.000162	0.000458	CcSEcCtD
Eszopiclone—Headache—Etoposide—uterine cancer	0.000161	0.000456	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—uterine cancer	0.00016	0.000454	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—uterine cancer	0.00016	0.000453	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—uterine cancer	0.000159	0.000451	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—uterine cancer	0.000158	0.000449	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—uterine cancer	0.000158	0.000449	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—uterine cancer	0.000158	0.000447	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—uterine cancer	0.000157	0.000444	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—uterine cancer	0.000156	0.000441	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—uterine cancer	0.000154	0.000436	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—uterine cancer	0.000153	0.000433	CcSEcCtD
Eszopiclone—Nausea—Etoposide—uterine cancer	0.000152	0.000432	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—uterine cancer	0.000152	0.000431	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000151	0.000429	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—uterine cancer	0.000151	0.000427	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—uterine cancer	0.00015	0.000425	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—uterine cancer	0.00015	0.000425	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—uterine cancer	0.00015	0.000425	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—uterine cancer	0.00015	0.000424	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—uterine cancer	0.000148	0.00042	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—uterine cancer	0.000147	0.000417	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—uterine cancer	0.000147	0.000416	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—uterine cancer	0.000147	0.000415	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—uterine cancer	0.000145	0.000411	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—uterine cancer	0.000144	0.000408	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—uterine cancer	0.000144	0.000408	CcSEcCtD
Eszopiclone—Infection—Epirubicin—uterine cancer	0.000143	0.000405	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—uterine cancer	0.000141	0.0004	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—uterine cancer	0.000141	0.000399	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—uterine cancer	0.00014	0.000398	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—uterine cancer	0.000139	0.000394	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—uterine cancer	0.000139	0.000394	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—uterine cancer	0.000139	0.000394	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—uterine cancer	0.000138	0.000392	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—uterine cancer	0.000137	0.000389	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—uterine cancer	0.000137	0.000389	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—uterine cancer	0.000136	0.000385	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—uterine cancer	0.000134	0.00038	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—uterine cancer	0.000133	0.000377	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—uterine cancer	0.000132	0.000375	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000131	0.000371	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—uterine cancer	0.00013	0.000369	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—uterine cancer	0.00013	0.000368	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—uterine cancer	0.000129	0.000366	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000129	0.000365	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—uterine cancer	0.000128	0.000363	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—uterine cancer	0.000128	0.000362	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—uterine cancer	0.000127	0.00036	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—uterine cancer	0.000127	0.000359	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—uterine cancer	0.000125	0.000354	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000124	0.000352	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—uterine cancer	0.000124	0.000352	CcSEcCtD
Eszopiclone—Pain—Epirubicin—uterine cancer	0.000123	0.000349	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—uterine cancer	0.000123	0.000349	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000121	0.000344	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—uterine cancer	0.00012	0.000341	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—uterine cancer	0.00012	0.000339	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—uterine cancer	0.000119	0.000336	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—uterine cancer	0.000119	0.000336	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—uterine cancer	0.000118	0.000335	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000118	0.000333	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—uterine cancer	0.000117	0.000332	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—uterine cancer	0.000116	0.000328	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000115	0.000326	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—uterine cancer	0.000115	0.000325	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—uterine cancer	0.000114	0.000324	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—uterine cancer	0.000114	0.000323	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—uterine cancer	0.000114	0.000323	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—uterine cancer	0.000114	0.000322	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—uterine cancer	0.000114	0.000322	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—uterine cancer	0.00011	0.000311	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000109	0.000308	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—uterine cancer	0.000106	0.0003	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—uterine cancer	0.000106	0.0003	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—uterine cancer	0.000105	0.000298	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—uterine cancer	0.000105	0.000298	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—uterine cancer	0.000103	0.000293	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—uterine cancer	0.000102	0.000288	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—uterine cancer	9.84e-05	0.000279	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—uterine cancer	9.81e-05	0.000278	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—uterine cancer	9.55e-05	0.000271	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—uterine cancer	9.51e-05	0.00027	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—uterine cancer	9.42e-05	0.000267	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—uterine cancer	9.15e-05	0.000259	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—uterine cancer	9.11e-05	0.000258	CcSEcCtD
Eszopiclone—Rash—Epirubicin—uterine cancer	9.07e-05	0.000257	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—uterine cancer	9.06e-05	0.000257	CcSEcCtD
Eszopiclone—Headache—Epirubicin—uterine cancer	9.01e-05	0.000255	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—uterine cancer	8.8e-05	0.000249	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—uterine cancer	8.55e-05	0.000242	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—uterine cancer	8.46e-05	0.00024	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—uterine cancer	8.39e-05	0.000238	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—uterine cancer	8.39e-05	0.000238	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—uterine cancer	8.34e-05	0.000236	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—uterine cancer	7.91e-05	0.000224	CcSEcCtD
